Autopsy report · NCT02972450
An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection
Cause of deathFunding or business
“Due to the bankruptcy of FITBiotech, the provider of the GTU DNA vaccine.”
Life of this trial
- Registered 2 years 3 months before it started.
- Ran for about 5 months before it stopped.
- 1 participant enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- ANRS, Emerging Infectious Diseases
- Sponsor type
- Government (non-US federal)
- Conditions
- HIV-1-infection
- Interventions
- GTU-MultiHIV B-clade vaccine + MVA HIV-B HIV vaccine; GTU-MultiHIV B-clade vaccine + MVA HIV-B HIV vaccine+ Vedolizumab; Vedolizumab 300 MG [Entyvio]; Placebo
- Participants
- 1
- Sites
- 2
- Countries
- Switzerland, United Kingdom
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.